Daiichi Sankyo Co Ltd (STU:D4S)
€ 29.4 -0.21 (-0.71%) Market Cap: 55.24 Bil Enterprise Value: 48.46 Bil PE Ratio: 37.21 PB Ratio: 5.53 GF Score: 93/100

Daiichi Sankyo Co Ltd R&D Day Transcript

Dec 15, 2020 / 10:00AM GMT
Release Date Price: €26.58 (-1.15%)
Junichi Onuma
Daiichi Sankyo Company, Limited - VP of Corporate Communications Department

Now we would like to start Daiichi Sankyo's R&D Day 2020. I am Junichi Onuma from the Corporate Communications Department. I'm delighted to serve as emcee today. Thank you for your time. Today, our President and CEO, Sunao Manabe; and our Global Head of Oncology R&D, Antoine Yver, will make presentations. After the presentations, we will have time to take your questions. Please note that the Q&A session will be recorded. Thank you for your understanding.

Now I'd like to hand it over to Manabe-san.

Sunao Manabe
Daiichi Sankyo Company, Limited - President, Group CEO & Representative Director

Hello, I'm Sunao Manabe, the CEO of Daiichi Sankyo. Thank you very much for joining Daiichi Sankyo's R&D Day 2020 during the busy end of the year season. This is the second time for me to host our R&D Day as CEO. I make much more important presentations in the course over the year, but I always enjoy to present here. I will present our progress over

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot